JAMA 2014-03-04, Vol. 311, No. 9, Author Audio Interview
Interview with Juan Jesús Carrero, PhD(Pharm and Med), author of Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - March 4, 2014 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Novel Anticoagulants vs Warfarin: Latest Analyses
For patients with atrial fibrillation, 4 novel anticoagulants appear to be slightly more effective and safer than warfarin for preventing ischemic stroke. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - January 30, 2014 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
JAMA 2013-11-17, Vol. 310, No. 19, Author Audio Interview
Interview with Prashanthan Sanders, MBBS, PhD, author of Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - November 17, 2013 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JEffect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial
Interview with Prashanthan Sanders, MBBS, PhD, author of Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - November 17, 2013 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Novel Oral Anticoagulants: A New Practical Guide
Guidance on the management of nonvalvular atrial fibrillation, from the European Heart Rhythm Association. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - November 12, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Are statins still safe?
Keith Fox, president of the British Cardiovascular Society, and Rory Collins, co-director of the University of Oxford's Clinical Trial Service Unit and Epidemiological Studies Unit, discuss the safety of statins, and how clever prescribing can overcome worries about myopathy. Also this week, Tony Delamothe, BMJ deputy editor, explains why the sudden interest in atrial fibrillation is making him queasy. (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 27, 2013 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Treating Atrial Fibrillation
(Source: Mayo Clinic - Medical Edge Radio)
Source: Mayo Clinic - Medical Edge Radio - August 26, 2013 Category: Consumer Health Advice Authors: Mayo Clinic Source Type: podcasts
Complications of Atrial Fibrillation
(Source: Mayo Clinic - Medical Edge Radio)
Source: Mayo Clinic - Medical Edge Radio - July 1, 2013 Category: Consumer Health Advice Authors: Mayo Clinic Source Type: podcasts
Atrial Fibrillation: A Growing Problem
(Source: Mayo Clinic - Medical Edge Radio)
Source: Mayo Clinic - Medical Edge Radio - April 29, 2013 Category: Consumer Health Advice Authors: Mayo Clinic Source Type: podcasts
#25: Preventing AF: The role of ACE inhibitors and ARBs
Popular treatment options fail to recognize AF as a consequence of other problems and instead attempt to treat atrial fibrillation as if it were the problem itself. (Source: Radio TheHeart.org)
Source: Radio TheHeart.org - February 15, 2013 Category: Cardiology Authors: theheart.org Tags: Mayo Clinic Talks Source Type: podcasts
Bleeding Risk in Afib? Don't Fear Warfarin
This F1000 commentary reports on a study whose findings support the use of antithrombotic therapy in treating patients with atrial fibrillation. (Source: Medscape Pharmacists Podcast)
Source: Medscape Pharmacists Podcast - February 1, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts
Will Apixaban Change Practice in Atrial Fibrillation?
The oral anticoagulant apixaban was recently approved in Europe for the prevention of stroke and systemic embolism in adults with nonvalvular atrial fibrillation. What role will this agent play? (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - January 9, 2013 Category: Cardiology Authors: Medscape Source Type: podcasts
